In the absence of diabetes specialists, primary care physicians who may not be well-versed in the cardiovascular benefits of GLP-1 RAs could be hesitant to modify therapies when glycaemic control is stable, and feel reluctant to prescribe these medications even for patients with cardiovascular disease [23, 25]
The meta-analysis was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols (PRISMA-P)
Accordingly, inhibition of both ACC1 and ACC2 was required to improve hepatic steatosis in mice [59], implying that both isoforms are important in NAFLD
whereas, an ether oxygen may serve only as an acceptor
which focused on the long-term efficacy of lycopene rather than its comparison with other therapeutic reagents (Kumar et al., 2007
You can see where these fit in out hormone therapy chart here